Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods

Kill curves were determined for five isolates of Bacteroides fragilis with clindamycin at concentrations equal to the MIC or to 4, 16, and 64 times the MIC. Examination of plots of log CFU per milliliter versus time revealed no association between the clindamycin concentration and the rate and extent of the bactericidal activity against B. fragilis at or below 64 times the MIC.

[1]  E. Begg,et al.  Comparison of gentamicin dosing regimens using an in-vitro model. , 1992, The Journal of antimicrobial chemotherapy.

[2]  G. Drusano,et al.  Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate , 1989, Antimicrobial Agents and Chemotherapy.

[3]  C H Nightingale,et al.  Experience with a once-daily aminoglycoside program administered to 2,184 adult patients , 1995, Antimicrobial agents and chemotherapy.

[4]  J. Turnidge,et al.  In vivo postantibiotic effect in a thigh infection in neutropenic mice. , 1988, The Journal of infectious diseases.

[5]  C. Wa,et al.  Killing and regrowth of bacteria in vitro: a review. , 1990 .

[6]  R. Townsend,et al.  Pharmacokinetic Comparison of Three Clindamycin Phosphate Dosing Schedules , 1987, Drug intelligence & clinical pharmacy.

[7]  W. Craig,et al.  Killing and regrowth of bacteria in vitro: a review. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[8]  D. Livingston,et al.  Continuous infusion of cefazolin is superior to intermittent dosing in decreasing infection after hemorrhagic shock. , 1993, American journal of surgery.

[9]  L. Nilsson,et al.  Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method. , 1988, The Journal of antimicrobial chemotherapy.

[10]  C. Stratton,et al.  Comparison of kill-kinetic studies with agar and broth microdilution methods for determination of antimicrobial activity of selected agents against members of the Bacteroides fragilis group , 1987, Journal of clinical microbiology.

[11]  T. Berne,et al.  Evaluation of two different dosage regimens of clindamycin and the penetration into human appendix. , 1989, Therapeutic drug monitoring.

[12]  W. Craig,et al.  Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. , 1989, The Journal of infectious diseases.

[13]  A. Karchmer,et al.  Selecting clindamycin dosage regimens. , 1987, American journal of hospital pharmacy.

[14]  I. Bakker-Woudenberg,et al.  Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. , 1985, The Journal of infectious diseases.

[15]  W. Craig,et al.  Postantibiotic suppression of bacterial growth. , 1981, Reviews of infectious diseases.

[16]  G. Drusano.  Human pharmacodynamics of beta-lactams, aminoglycosides and their combination. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[17]  D. Nicolau,et al.  Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections , 1994, Antimicrobial Agents and Chemotherapy.

[18]  B. D. Davis.  Mechanism of bactericidal action of aminoglycosides , 1987, Microbiological reviews.

[19]  J. Mordenti,et al.  Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model. , 1985, Journal of Antimicrobial Chemotherapy.

[20]  M. Nishida,et al.  Bactericidal Activity of Cephalosporins in an In Vitro Model Simulating Serum Levels , 1978, Antimicrobial Agents and Chemotherapy.

[21]  B. Guglielmo,et al.  Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens , 1988, Antimicrobial Agents and Chemotherapy.

[22]  J. Avorn,et al.  Effect of hospitalwide change in clindamycin dosing schedule on clinical outcome. , 1989, Reviews of infectious diseases.